BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 28045158)

  • 1. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
    Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
    Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention.
    Zhang A; Liu Q; Zhao H; Zhou X; Sun H; Nan Y; Zou S; Ma CW; Wang X
    Sci Rep; 2016 Jan; 6():19333. PubMed ID: 26785698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary metabonomic study of Panax ginseng in deficiency of vital energy rat using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Lin H; Pi Z; Men L; Chen W; Liu Z; Liu Z
    J Ethnopharmacol; 2016 May; 184():10-7. PubMed ID: 26921673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profiling reveals therapeutic biomarkers of processed Aconitum carmichaeli Debx in treating hydrocortisone induced kidney-yang deficiency syndrome rats.
    Tan Y; Liu X; Lu C; He X; Li J; Xiao C; Jiang M; Yang J; Zhou K; Zhang Z; Zhang W; Lu A
    J Ethnopharmacol; 2014 Mar; 152(3):585-93. PubMed ID: 24556226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the anti-hypertensive effect of Tengfu Jiangya tablet by combination of UPLC-Q-exactive-MS-based metabolomics and iTRAQ-based proteomics technology.
    Tian Y; Jiang F; Li Y; Jiang H; Chu Y; Zhu L; Guo W
    Biomed Pharmacother; 2018 Apr; 100():324-334. PubMed ID: 29453042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods.
    Dong H; Zhang A; Sun H; Wang H; Lu X; Wang M; Ni B; Wang X
    Mol Biosyst; 2012 Apr; 8(4):1206-21. PubMed ID: 22282765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput metabolomic approach to explore the regulatory effect of mangiferin on metabolic network disturbances of hyperlipidemia rats.
    Zhou C; Li G; Li Y; Gong L; Huang Y; Shi Z; Du S; Li Y; Wang M; Yin J; Sun C
    Mol Biosyst; 2015 Feb; 11(2):418-33. PubMed ID: 25406416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome.
    Nan Y; Zhou X; Liu Q; Zhang A; Guan Y; Lin S; Kong L; Han Y; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():217-226. PubMed ID: 26747643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary metabolomics study the mechanism of Taohong Siwu Decoction intervention in acute blood stasis model rats based on liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Zhang X; Li P; Hua Y; Ji P; Yao W; Ma Q; Yuan Z; Wen Y; Yang C; Wei Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():51-60. PubMed ID: 29331744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Systems Pharmacology, Urinary Metabonomics, and Quantitative Real-Time PCR Analysis to Uncover Targets and Metabolic Pathways of the You-Gui Pill in Treating Kidney-Yang Deficiency Syndrome.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
    Ji H; Liu Y; He F; An R; Du Z
    J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China.
    Jiang N; Liu HF; Li SD; Zhou WX; Zhang YX; Zhang Q; Yan XZ
    Acta Pharmacol Sin; 2015 Jun; 36(6):689-98. PubMed ID: 25937635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics-proteomics profiles delineate metabolic changes in kidney fibrosis disease.
    Cao H; Zhang A; Sun H; Zhou X; Guan Y; Liu Q; Kong L; Wang X
    Proteomics; 2015 Nov; 15(21):3699-710. PubMed ID: 26256572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput chinmedomics-based prediction of effective components and targets from herbal medicine AS1350.
    Liu Q; Zhang A; Wang L; Yan G; Zhao H; Sun H; Zou S; Han J; Ma CW; Kong L; Zhou X; Nan Y; Wang X
    Sci Rep; 2016 Dec; 6():38437. PubMed ID: 27910928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabonomic study of Wu-tou decoction in adjuvant-induced arthritis rat using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Qi Y; Li S; Pi Z; Song F; Lin N; Liu S; Liu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():11-9. PubMed ID: 24561351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the effective substance of the Wu-tou formula based on the metabonomic method using UPLC-Q-TOF-HDMS.
    Xu T; Liu S; Zhao J; Feng G; Pi Z; Song F; Liu Z
    Mol Biosyst; 2015 Nov; 11(11):3081-91. PubMed ID: 26338656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on chemical constituents of herbal formula Er Miao Wan and GC-MS based metabolomics approach to evaluate its therapeutic effects on hyperuricemic rats.
    Huang B; Hu X; Wang J; Li P; Chen J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():101-108. PubMed ID: 31030102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach.
    Wang X; Yang B; Zhang A; Sun H; Yan G
    J Proteomics; 2012 Feb; 75(4):1411-27. PubMed ID: 22134358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and metabolomics analyses reveal the full spectrum of inflammatory and lipid metabolic abnormalities in dyslipidemia.
    Du H; Rao Y; Liu R; Deng K; Guan Y; Luo D; Mao Q; Yu J; Bo T; Fan Z; Ouyang H; Feng Y; Zhu W
    Biomed Chromatogr; 2021 Oct; 35(10):e5183. PubMed ID: 34058018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.